GUILFORD, Conn., July 30, 2026
Hyperfine, Inc. announced the publication of multiple peer-reviewed clinical studies highlighting the expanding role of its FDA-cleared AI-powered Swoop® Portable MRI System across stroke care, neurosurgery, emergency medicine, and critical care. The latest research, published in the Journal of Neurosurgery and Stroke, provides new evidence demonstrating how the portable ultra-low-field MRI system can improve clinical decision-making by delivering rapid bedside brain imaging in settings where conventional MRI is often unavailable or impractical. The publications further strengthen Hyperfine’s growing clinical evidence base, which now includes more than 180 peer-reviewed publications and editorials along with over 280 scientific presentations, supporting broader adoption of the Swoop® system across multiple healthcare environments. The company believes these findings reinforce the value of portable MRI technology in improving patient access to timely neuroimaging while reducing delays in diagnosis and treatment.
New Publications Demonstrate Clinical Value in Stroke and Neurosurgery
The July 2026 issue of the Journal of Neurosurgery featured clinical cases conducted at an ambulatory neurosurgery center, where the Swoop® Portable MRI System enabled immediate post-procedural brain imaging following endovascular neurosurgical procedures. The studies showed the system could rapidly confirm the absence of complications such as acute ischemic stroke or intracranial hemorrhage, allowing clinicians to confidently support same-day patient discharge. Immediate neurological assessment following surgery is essential for identifying complications and guiding treatment decisions, yet conventional MRI frequently presents logistical challenges due to limited accessibility and patient transport requirements. The newly published findings suggest that portable MRI may provide an efficient alternative by delivering imaging directly at the point of care, potentially improving workflow efficiency while enhancing patient safety in neurosurgical settings.
Stroke Research Supports Broader Adoption of Portable MRI
In addition to the neurosurgical findings, the journal Stroke published a dedicated collection of articles examining the role of low-field MRI throughout the stroke care continuum, including pre-hospital stroke assessment, emergency departments, acute stroke treatment, neurocritical care, and cerebral small vessel disease. The articles combine existing clinical evidence with new research and practical implementation guidance, highlighting the growing importance of portable MRI technology in modern stroke management. According to Hyperfine Chief Medical Officer Dr. Edmond Knopp, the expanding body of evidence demonstrates that the Swoop® system is evolving beyond its initial use in intensive care settings into broader clinical environments where rapid access to brain imaging can improve patient management. The publications collectively strengthen clinician confidence in portable MRI as an emerging imaging solution capable of supporting faster diagnosis, treatment planning, and patient monitoring across multiple healthcare settings.
Advertisement
Growing Evidence Reinforces Hyperfine’s Innovation Strategy
The latest publications represent another milestone in Hyperfine’s mission to make advanced brain imaging more accessible, efficient, and cost-effective through portable technology. The FDA-cleared Swoop® Portable MRI System is approved for brain imaging of patients of all ages and is designed for situations where conventional full-scale MRI is not clinically practical. By combining AI-powered imaging, portable ultra-low-field MRI technology, and expanding peer-reviewed validation, Hyperfine continues to position the Swoop system as a transformative diagnostic platform capable of supporting hospitals, emergency departments, stroke centers, and ambulatory surgical facilities worldwide. As clinical evidence continues to expand, the company believes portable MRI technology has the potential to reshape neuroimaging workflows by bringing high-quality brain imaging directly to the patient, improving access while supporting faster and more informed clinical decisions.
Source: Hyperfine ,press release
